Activated caspase-3 expression in Alzheimer’s and aged control brain: correlation with Alzheimer pathology

Several studies have suggested that activated caspase-3 has properties of a cell death executioner protease. In this study, we examined the expression of activated caspase-3 in AD and aged control brains. Activated caspase-3 immunoreactivity was seen in neurons, astrocytes, and blood vessels, was elevated in AD, and exhibited a high degree of colocalization with neurofibrillary tangles and senile plaques. These data suggest that activated caspase-3 may be a factor in functional decline and may have an important role in neuronal cell death and plaque formation in AD brain.

[1]  D. Holtzman,et al.  In situ immunodetection of neuronal caspase-3 activation in Alzheimer disease. , 1999, Journal of neuropathology and experimental neurology.

[2]  S. Nagata,et al.  Apoptosis by Death Factor , 1997, Cell.

[3]  N. Marks,et al.  Recent advances on neuronal caspases in development and neurodegeneration , 1999, Neurochemistry International.

[4]  C. Cotman,et al.  Apoptosis is induced by beta-amyloid in cultured central nervous system neurons. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[5]  C. Cotman,et al.  Mechanisms of Neuronal Death in Alzheimer's Disease , 1996, Brain pathology.

[6]  G. Häcker,et al.  Activation of caspase‐3‐like enzymes in non‐apoptotic T cells , 1998, European journal of immunology.

[7]  D. Selkoe.  The molecular pathology of Alzheimer's disease , 1991, Neuron.

[8]  Patrick R. Griffin,et al.  Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis , 1995, Nature.

[9]  J. Schulz,et al.  Neuroprotection by the Inhibition of Apoptosis , 2000, Brain pathology.

[10]  David Smith,et al.  Involvement of Caspases in Proteolytic Cleavage of Alzheimer’s Amyloid-β Precursor Protein and Amyloidogenic Aβ Peptide Formation , 1999, Cell.

[11]  K. Roth,et al.  In situ immunodetection of activated caspase-3 in apoptotic neurons in the developing nervous system , 1998, Cell Death and Differentiation.

[12]  I. Ferrer,et al.  Role of caspases in ionizing radiation-induced apoptosis in the developing cerebellum. , 1999, Journal of neurobiology.

[13]  J. Velier,et al.  Caspase-8 and Caspase-3 Are Expressed by Different Populations of Cortical Neurons Undergoing Delayed Cell Death after Focal Stroke in the Rat , 1999, The Journal of Neuroscience.

[14]  Emad S. Alnemri,et al.  Activation of a CrmA-insensitive, p35-sensitive Pathway in Ionizing Radiation-induced Apoptosis* , 1997, The Journal of Biological Chemistry.

[15]  Dennis J. Selkoe.  Physiological production of the β-amyloid protein and the mechanism of Alzheimer's disease , 1993, Trends in Neurosciences.

[16]  C. Cotman,et al.  DNA Damage and Activated Caspase-3 Expression in Neurons and Astrocytes: Evidence for Apoptosis in Frontotemporal Dementia , 2000, Experimental Neurology.

[17]  M. Moskowitz,et al.  Activation and Cleavage of Caspase-3 in Apoptosis Induced by Experimental Cerebral Ischemia , 1998, The Journal of Neuroscience.

[18]  E. Hirsch,et al.  Caspase-3: A vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[19]  H. Mehmet,et al.  Apoptosis: Caspases find a new place to hide , 2000, Nature.

[20]  C. Barbato,et al.  Tau Cleavage and Dephosphorylation in Cerebellar Granule Neurons Undergoing Apoptosis , 1998, The Journal of Neuroscience.

[21]  C. Peschle,et al.  Caspase activation without death , 1999, Cell Death and Differentiation.

[22]  K. Jellinger,et al.  Activation of caspase-3 in single neurons and autophagic granules of granulovacuolar degeneration in Alzheimer's disease. Evidence for apoptotic cell death. , 1999, The American journal of pathology.

[23]  G. Forloni,et al.  Apoptosis mediated neurotoxicity induced by chronic application of beta amyloid fragment 25-35. , 1993, Neuroreport.

[24]  John Q. Trojanowski,et al.  Abnormal tau phosphorylation at Ser396 in alzheimer's disease recapitulates development and contributes to reduced microtubule binding , 1993, Neuron.

[25]  J B Schulz,et al.  Caspases as treatment targets in stroke and neurodegenerative diseases , 1999, Annals of neurology.

[26]  A. Klug,et al.  Structural characterization of the core of the paired helical filament of Alzheimer disease. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[27]  E. Mandelkow,et al.  The switch of tau protein to an Alzheimer‐like state includes the phosphorylation of two serine‐proline motifs upstream of the microtubule binding region. , 1992, The EMBO journal.

[28]  Y. Lazebnik,et al.  Caspases: enemies within. , 1998, Science.

[29]  L. Iversen,et al.  The toxicity in vitro of beta-amyloid protein. , 1995, The Biochemical journal.

[30]  T. Ley,et al.  Cleavage of CPP32 by Granzyme B Represents a Critical Role for Granzyme B in the Induction of Target Cell DNA Fragmentation* , 1996, The Journal of Biological Chemistry.

[31]  Brian J Cummings,et al.  Immunohistochemical evidence for apoptosis in Alzheimer's disease. , 1994, Neuroreport.